```html

Xerostomia‑Associated Candidiasis

Overview

Xerostomia‑associated candidiasis (often called “dry‑mouth thrush”) is a fungal infection of the oral cavity that occurs when reduced saliva flow (xerostomia) creates an environment in which Candida species, most commonly Candida albicans, can overgrow. Saliva normally washes away microbes, supplies antimicrobial proteins, and maintains a balanced oral pH. When saliva production drops, these protective mechanisms falter, allowing yeast to proliferate on the mucosa, tongue, and palate.

The condition primarily affects adults over 50 years of age, but it can occur at any age when xerostomia is present. It is especially common among:

• Patients taking anticholinergic medications, antihistamines, or certain antidepressants.
• Individuals with autoimmune diseases such as Sjögren’s syndrome.
• Radiation therapy recipients (especially head‑and‑neck cancer patients).
• People with poorly controlled diabetes mellitus.

Prevalence estimates vary by population, but studies suggest that up to 30 % of patients with chronic xerostomia develop oral candidiasis at some point, compared with < 5 % in the general population (Mayo Clinic, 2023; NIH Oral Health Study, 2022).

Symptoms

Symptoms may be subtle early on and progress as the infection spreads. Common manifestations include:

• White, creamy plaques on the tongue, inner cheeks, gums, or roof of the mouth that can be wiped off, sometimes leaving a reddened base.
• Redness and soreness of the oral mucosa, especially after brushing or eating acidic foods.
• Burning sensation that mimics “mouth‑burn” or a feeling of heat in the tongue.
• Dryness or “cotton‑mouth” feeling that is not relieved by drinking fluids.
• Altered taste (dysgeusia) – often described as metallic, sour, or bitter.
• Difficulty swallowing (dysphagia) or a feeling that food sticks in the throat.
• Cracking at the corners of the mouth (angular cheilitis), which may be painful.
• Red, shiny lesions on the palate or throat in severe cases.
• Bad breath (halitosis) due to yeast metabolism.

In immunocompromised patients, candidiasis can become invasive, leading to systemic symptoms such as fever, chills, and malaise—requiring urgent medical attention.

Causes and Risk Factors

Primary Causes

1. Reduced Saliva Production (Xerostomia) – caused by medications, disease, or radiation.
2. Disruption of Oral Microbiome – antibiotics or antiseptic mouthwashes can diminish bacterial competitors, allowing Candida to dominate.
3. High Oral Sugar Levels – poorly controlled diabetes or frequent consumption of sugary drinks provide a nutrient source for yeast.

Key Risk Factors

• Medications: anticholinergics (e.g., diphenhydramine), antihistamines, tricyclic antidepressants, antipsychotics, and certain chemotherapy agents.
• Systemic Diseases: Sjögren’s syndrome, HIV/AIDS, uncontrolled diabetes, and autoimmune disorders.
• Radiation Therapy: especially for head‑and‑neck cancers – can diminish salivary gland function permanently.
• Age: salivary gland output naturally declines after age 60.
• Smoking & Alcohol: both irritate oral mucosa and alter saliva composition.
• Poor Oral Hygiene: accumulation of plaque and denture biofilm fosters yeast growth.
• Immunosuppression: organ transplant recipients, patients on corticosteroids or biologics.

Understanding these factors helps clinicians target both the underlying xerostomia and the fungal overgrowth.

Diagnosis

Diagnosis is usually clinical but may be confirmed with laboratory tests to guide therapy.

Clinical Examination

• Visual inspection of plaques, erythema, and any erythematous base after wiping.
• Evaluation of saliva flow – unstimulated whole‑saliva flow rate < 0.1 mL/min is considered xerostomic.

Laboratory Tests

1. Microscopy & Gram Stain of a scrapings – shows budding yeast and pseudohyphae.
2. Culture on Sabouraud dextrose agar – identifies Candida species and antifungal susceptibility.
3. PCR or MALDI‑TOF – rapid species identification, especially for non‑albicans Candida.
4. Salivary Flow Assessment – sialometry or sialochemistry to quantify and evaluate quality.
5. Blood Tests (if invasive disease suspected): CBC, blood cultures, and serum β‑D‑glucan.

For patients with denture‑related thrush, a denture hygiene assessment is also performed.

Treatment Options

Effective management requires addressing both the fungal infection and the underlying xerostomia.

Antifungal Medications

Drug	Formulation	Typical Duration	Key Considerations
Nystatin	Oral suspension (swish‑spit) 4‑6 × daily	7‑14 days	Safe in pregnancy; taste disturbance common.
Clotrimazole	Troches (lozenges) 5 × daily	7‑14 days	May cause local irritation.
Fluconazole	Oral tablet 100–200 mg once daily	7‑14 days (longer if refractory)	Systemic; watch for drug interactions (CYP450).
Itraconazole	Oral solution or capsules	14‑21 days	Useful for non‑albicans species; monitor liver enzymes.

Patients with recurrent infection may need a maintenance regimen (e.g., weekly nystatin swish‑spit) and susceptibility‑guided therapy.

Managing Xerostomia

• Saliva Substitutes – OTC sprays, gels, or lozenges containing carboxymethylcellulose or glycerin.
• Saliva Stimulants – sugar‑free chewing gum, pilocarpine (5 mg PO tid), or cevimeline (30 mg PO tid) for patients with residual gland function.
• Hydration – sip water frequently; avoid caffeine and alcohol.
• Prescription Sialagogues – consider in severe cases after evaluating contraindications (e.g., uncontrolled asthma).

Adjunctive Oral Care

• Gentle brushing with a soft‑bristled toothbrush twice daily.
• Alcohol‑free fluoride toothpaste.
• Daily denture cleaning; remove dentures at night.
• Use of a diluted chlorhexidine mouth rinse (0.12 %) for 30 seconds, 2 × daily – limited to 2 weeks to avoid staining.

Procedural Options (Rare)

• Laser or photodynamic therapy – emerging evidence for refractory oral thrush.
• Minor surgical debridement of hyperkeratotic lesions (typically in immunocompromised hosts).

Living with Xerostomia‑Associated Candidiasis

Daily Management Tips

• Maintain a Moist Oral Environment – keep a bottle of water at bedside; sip before bedtime.
• Optimize Nutrition – choose soft, non‑acidic foods; limit sugary snacks.
• Oral Hygiene Routine:
  1. Brush after every meal.
  2. Floss gently; consider floss holders if manual dexterity is limited.
  3. Rinse with a saliva‑substitute spray after meals.
• Monitor for Recurrence – keep a brief log of symptoms; note any new medication changes.
• Denture Care – soak dentures overnight in a mild disinfectant (e.g., alkaline peroxide) and brush them daily.
• Regular Dental Visits – at least twice a year, or more often if you have active candidiasis.
• Stress & Sleep – adequate sleep and stress‑reduction techniques improve immune function.

Prevention

Preventing xerostomia and subsequent candidiasis focuses on preserving saliva flow and controlling yeast growth.

• Review medication lists with your physician; seek alternatives with less anticholinergic burden.
• Control blood glucose tightly if you have diabetes (target HbA1c < 7 %).
• Use a humidifier at night, especially in dry climates.
• Avoid tobacco, limit alcohol, and steer clear of recreational drugs.
• Chew sugar‑free xylitol gum – stimulates saliva and may reduce bacterial load.
• Limit mouthwashes that contain alcohol; prefer fluoride‑only rinses.
• Vaccinate against influenza and COVID‑19 – systemic infections can exacerbate oral candidiasis.

Complications

If left untreated, xerostomia‑associated candidiasis can lead to:

• Extension to the Esophagus – causing odynophagia, weight loss, and risk of perforation.
• Chronic Angular Cheilitis – painful fissures that may become secondarily infected.
• Dental Caries & Root Decay – saliva’s buffering capacity is lost, accelerating enamel erosion.
• Systemic Candidemia – rare but serious in immunocompromised patients; associated mortality up to 40 % (CDC, 2021).
• Quality‑of‑Life Impact – difficulty eating, speaking, and social embarrassment.

When to Seek Emergency Care

References

• Mayo Clinic. “Dry mouth (xerostomia).” Updated 2023. https://www.mayoclinic.org
• National Institutes of Health. “Oral Candidiasis.” Oral Health Research, 2022. https://www.nih.gov
• Centers for Disease Control and Prevention. “Candidiasis – Antifungal‑Resistant Yeast Infections.” 2021. https://www.cdc.gov
• World Health Organization. “Oral Health Fact Sheet.” 2022. https://www.who.int
• Cleveland Clinic. “Xerostomia (Dry Mouth) Treatment.” 2024. https://my.clevelandclinic.org
• Ranganathan, K., et al. “Management of Oral Candidiasis in the Elderly.” *J Oral Med Pathol*, 2023; 52(2): 123‑131.

```